Experienced in Properdin Deficiency

Flavia M. Cicuttini

Commercial Road, 
Melbourne, VIC, AU 
Experienced in Properdin Deficiency
Commercial Road, 
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Flavia Cicuttini practices in Melbourne, Australia. Ms. Cicuttini is rated as an Experienced expert by MediFind in the treatment of Properdin Deficiency. Her top areas of expertise are Osteoarthritis, Arthritis, Obesity, Knee Replacement, and Hip Replacement.

Her clinical research consists of co-authoring 444 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Properdin Deficiency.

Gender
Female

Locations

Commercial Road, Melbourne, VIC, Australia
Other Locations
553 St Kilda Road, Melbourne, VIC 3004, Australia
Commercial Road, Melbourne, VIC 3181, Australia
Level 5 / Block E, 246 Clayton Road, Clayton, VIC 3168, Australia
Commercial Rd, Melbourne, VIC 3004, Australia
Building 1, 270 Ferntree Gully Road, Ferntree Gully, VIC 3168, Australia
Level 5, 246 Clayton Road, Clayton, VIC 3168, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Double-Blind, Placebo-Controlled Assessment of the Tolerability and Efficacy of XT-150 for the Treatment of Moderate to Severe Pain Due to Osteoarthritis of the Knee
A Double-Blind, Placebo-Controlled Assessment of the Tolerability and Efficacy of XT-150 for the Treatment of Moderate to Severe Pain Due to Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: March 27, 2025
Intervention Type: Drug, Biological
Study Drug: XT-150 Plasmid DNA
Study Phase: Phase 2
A Placebo-controlled, Double-blind Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Facet Joint Osteoarthritis Pain
A Placebo-controlled, Double-blind Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Facet Joint Osteoarthritis Pain
Enrollment Status: Withdrawn
Publish Date: March 17, 2022
Intervention Type: Biological
Study Drug: XT-150
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

444 Total Publications

Metformin for Treatment of Knee Osteoarthritis in Patients With Overweight or Obesity-Reply.
Metformin for Treatment of Knee Osteoarthritis in Patients With Overweight or Obesity-Reply.
Journal: JAMA
Published: August 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cicuttini's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile